African american men's and women's perceptions of clinical trials research: Focusing on prostate cancer among a high- risk population in the South

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 4, 2013, Pages 1784-1800

  Owens, Otis L ^b   Jackson, Dawnyéa D ^b   Thomas, Tracey L ^b   Friedman, Daniela B ^a   Hébert, James R ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Epidemiology and Biostatistics ^*

Author keywords

African americans; Barriers; Cancer research; Clinical trials; Motivators; Participation

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; BLACK PERSON; CLINICAL TRIAL (TOPIC); ETHNOLOGY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PATIENT ATTITUDE; PROSTATE TUMOR; QUESTIONNAIRE; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIALS AS TOPIC; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SOUTH CAROLINA;

EID: 84887048525     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2013.0187     Document Type: Article

References (78)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, GA; 2012
2. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advancedstage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001 Mar 7;93(5):388-395
3. Bennett CL, Weinberg PD, Lieberman JJ. Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan;168(1):17-22
4. Arbes SJ, Jr., Olshan AF, Caplan DJ, et al. Factors contributing to the poorer survival of black Americans diagnosed wiThoral cancer (United States). Cancer Causes Control. 1999 Jun 25;10(6):513-523
5. Heiney SP, Adams SA, Drake BF, Bryant LH, Bridges L, Hebert JR. Successful subject recruitment for a prostate cancer behavioral intervention trial. Clin Trials. 2010 Aug 6;7(4):411-417. Epub 2010 Jun 22
6. Branson RD, Davis K, Jr., Butler KL. African Americans' participation in clinical research: importance, barriers, and solutions. Am J Surg. 2007 Jan;193(1):32-39; discussion 40
7. Gross CP, Filardo G, Mayne ST, Krumholz HM. The impact of socioeconomic status and race on trial participation for older women wiThbreast cancer. Cancer. 2005 Feb 1;103(3):483-491
8. United States Cancer Statistics: 1999-2003 incidence and mortality web- based report. US DHHS/ CDC/ NIH- NCI; 2006. Available at http://www.cdc.gov/cancer/npcr/uscs.
9. Drake BF, Keane TE, Mosley CM, et al. Prostate cancer disparities in SouThCarolina: Early detection, special programs, and descriptive epidemiology. J SouThCarolina Med Assoc. 2006;102:241-249
10. Hebert JR, Daguise VG, Hurley DM, et al. Mapping cancer mortality- to-incidence ratios to illustrate racial and gender disparities in a high- risk population. Cancer. 2009 Jun 1;115(11):2539-2552
11. Andriole GL, Crawford ED, Grubb RL, et al. Mortality results from a randomized prostate- cancer screening trial. N Engl J Med. 2009 Mar 26;360(13):1310-1319. Epub 2009 Mar 18
12. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate- cancer mortality in a randomized European study. N Engl J Med. 2009 Mar 26;360(13):1320-1328. Epub 2009 Mar 18
13. U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement DRAFT. 2011. Available at http://www.uspreventiveservicestaskforce.org/draftrec3.htm.
14. SmiThRA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA: Cancer J for Clin. 2011 Jan-Feb 4;61(1):8-30. Epub 2011 Jan 4
15. Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: Update 2010. CA: Cancer J for Clin. 2010 Mar 3;60(2):70-98. Epub 2010 Mar 3
16. Christian MC, Trimble EL. Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):277s-283s.
17. Baquet CR, Ellison GL, Mishra SI. Analysis of Maryland cancer patient participation in National Cancer Institute- supported cancer treatment clinical trials. J Clin Oncol. 2008 Jul 10;26(20):3380-3386
18. U.S. National Institute of Health. ClinicalTrials.gov. Understanding Clinical Trials. 2007 Available at http://www.clinicaltrials.gov/ct2/info/understand.
19. Freedman LS, Simon R, Foulkes MA, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-the perspective of NIH clinical trialists. Control Clin Trials. 1995 Oct16(5):277-285; discussion 286-9, 293-309
20. Food and Drug Administration (FDA). FDA Modernization Act of 1997 (Public Law 105-15);1997
21. Moinpour CM, Atkinson JO, Thomas SM, et al. Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol. 2000 Nov;10(8 Suppl):S85-91
22. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002 Apr 15;20(8):2109-17
23. Comis RL, Crowley J, Unger J, et al. Baseline study of patient accrual onto publicly sponsored U.S. cancer clinical trials: an analysis conducted for the global access project of the National Patient Advocate Foundation. 2006; Available at http://www.npaf.org/ images/pdf/gap/sept_2006/cccg.pdf.
24. Ford ME, Havstad SL, Tilley BC. Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist. 2003 Feb;43(1):27-35
25. Reed PS, Long Foley K, Hatch J, et al. Recruitment of older African Americans for survey research: a process evaluation of the community and church- based strategy in the Durham Elders Project. Gerontologist. 2003 Feb;43(1):52-61
26. Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist. 2003 Feb;43(1):62-72
27. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008 Nov 15;112(2): 228-42
28. Chandra A, Paul DP, 3rd. African American participation in clinical trials: recruitment difficulties and potential remedies. Hosp Top. 2003;81(2):33-8
29. Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005 Jul;97(7):951-6
30. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that infl uence the willingness to participate in medical research studies. Ann Epidemiol. 2002 May;12(4):248-56
31. Seto B. History of medical ethics and perspectives on disparities in minority recruitment and involvement in healThresearch. Am J Med Sci. 2001 Nov;322(5):248-50
32. Williams MM, ScharffDP, Mathews KJ, et al. Barriers and facilitators of African American participation in Alzheimer disease biomarker research. Alzheimer Dis. Assoc. Disord. 2010 Jul;24(9):S24-9
33. Linden HM, Reisch LM, Hart AJ, et al. Attitudes toward participation in breast cancer randomized clinical trials in the African American Community: a focus group study. Cancer Nurs. 2007 July;30(4):261-9
34. Ford JG, Howerton MW, Bolen S, et al. Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ). 2005 Jun;(122):1-11
35. Adams- Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004 Feb 15;22(4):730-4
36. Patel K, Kenerson D, Wang H, et al. Factors infl uencing prostate cancer screening in low- income African Americans in Tennessee. J HealThCare Poor Underserved. 2010 Feb;21(1 Suppl):114-26
37. Klamerus JF, Bruinooge SS, Ye X, et al. The impact of insurance on access to cancer clinical trials at a comprehensive cancer center. Clin. Cancer Res. 2010 Dec 15;16(24):5997-6003
38. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African American patients wiThcancer in clinical trials: a pilot study. Cancer. 2003 Mar 15;97(6):1499-1506
39. Lara PN, Jr., Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005 Dec 20;23(36):9282-9
40. TrauThJM, Jernigan JC, SiminoffLA, et al. Factors affecting older African American women's decisions to join the PLCO Cancer Screening Trial. J Clin Oncol. 2005 Dec 1;23(34):8730-8
41. Howerton MW, Gibbons MC, BaffiCR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer. 2007 Feb 1;109(3):465-476
42. Pinto HA, McCaskill- Stevens W, Wolfe P, et al. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) initiative. Ann Epidemiol. 2000 Nov;10(8 Suppl):S78-S84
43. McCaskill- Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999 Mar;17(3): 1029-1039
44. Gross CP, Herrin J, Wong N, et al. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol. 2005 Jul 20;23(21):4755-4763
45. Joseph G, Dohan D. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety- net hospital. Contemp Clin Trials. 2009 Nov;30(6):552-559. Epub 2009 Jul 4
46. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the infl uence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000 Nov;10(8 Suppl):S22-S34
47. Hoffman- Goetz L, Friedman DB. A qualitative study of Canadian Aboriginal women's beliefs about "credible" cancer information on the internet. J Cancer Educ. 2007 Dec 5;22(2):124-128
48. Friedman DB, Corwin SJ, Rose ID, et al. Prostate cancer communication strategies recommended by older African American men in SouThCarolina: a qualitative analysis. J Cancer Educ. 2009;24(3):204-209
49. Minkler M, Wallerstein N. Community- Based participatory research for health. eds. San Francisco, CA: Josey- Bass,2003
50. Israel BA, Schulz AJ, Parker EA, et al. Critical issues in developing and following community based participatory research principles. In: Minkler M WN, ed. Community- Based participatory research for health. San Francisco: Jossey- Bass, 2003
51. U.S. Department of HealThand Human Services. Office of Disease Prevention and HealThPromotion. Healthy People 2020. Washington, DC. 2010. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=18
52. Doak CC, Doak LG, Root JH. Teaching patients wiThlow literacy skills. Philadelphia, Pennsylvania: Lippincott Company, 1996
53. Friedman DB, Johnson KM, Owens O, et al. Developing partnerships and recruiting dyads for a prostate cancer informed decision making program: lessons learned from a community- academic- clinical team. J Cancer Educ. 2012. Jun 27(2):243-249
54. Jones RA, Taylor AG, Bourguignon C, et al. Family interactions among African American prostate cancer survivors. Fam Community Health. 2008 Jul-Sep;31(3):213-220
55. Levinson W, Kao A, Kuby A, et al. Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med. 2005 Jun;20(6):531-535
56. Davison BJ, Degner LF, Morgan TR. Information and decision- making preferences of men wiThprostate cancer. Oncol Nurs Forum. 1995 Oct;22(9):1401-1408
57. QSR NVivo. Version 9. Melbourne, AU: Qualitative Solutions and Research Pty Ltd, 2010
58. Strauss A, Corbin J. Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage Publications, 1998
59. SPSS. Version 18. Chicago, IL, 2009
60. Rosner B, Glynn RJ, Ting Lee M-L. Incorporation of clustering effects for the Wilcoxon Rank Sum Test: a large- sample approach. Biometrics. 2003 Dec;59(4):1089-1098
61. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947 June;12(2):153-157
62. Bowker AH. A test for symmetry in contingency tables. Journal of the American Statistical Association. 1948 Dec;43(244):572-574
63. Carter VL, Tippett F, Anderson DL, Tameru B. Increasing prostate cancer screening among African American men. J HealThCare Poor Underserved. 2010 Aug;21(3 Suppl):91-106
64. US Cancer Statistics Working Group. United States Cancer Statistics:1999-2007 Incidence and Mortality Web- based Report: U.S. Department of HealThand Human Services Centers for Disease Control and Prevention and National Cancer Institute;2011
65. Wagner SE, Hurley DM, Hebert JR, et al. Cancer mortality- to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants. Cancer. 2012 Aug 15;118(16):4032-4045
66. ScharffDP, Mathews KJ, Jackson P, et al. More than Tuskegee: understanding mistrust about research participation. J HealThCare Poor Underserved. 2010 Aug;21(3):879-897
67. Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore). 2008 Jan;87(1):1-9
68. Ballard EL, Gwyther LP, Edmonds HL. Challenges and opportunities: recruitment and retention of African Americans for Alzheimer disease research: lessons learned. Alzheimer Dis. Assoc. Disord. 2010 Jul-Sep;24:S19-S23
69. Wray RJ, Vijaykumar S, Jupka K, et al. Addressing the challenge of informed decision making in prostate cancer community outreach to African American men. Am J Mens Health. 2011 Nov1;5(6):508-516. Epub 2011 Aug 3
70. O'Brien MA, Whelan TJ, Villasis- Keever M, et al. Are cancer- related decision aids effective? A systematic review and meta- analysis. J. Clin. Oncol. 2009 Feb20;27(6):974-985. Epub 2009 Jan 5
71. Stunkel L, Grady C. More than the money: a review of the literature examining healthy volunteer motivations. Contemporary clinical trials. 2011 May;32(3):342-352. Epub 2010 Dec 10
72. Largent E, Grady C, Miller F, et al. Money, Coercion, and Undue Inducement: Attitudes about Payments to Research Participants. IRB. 2012 Jan-Feb;34(1):1-8
73. Singer E, Couper MP. Do Incentives Exert Undue Infl uence on Survey Participation? Experimental Evidence. J Empir Res Hum Res Ethics. 2008 Sept;3(3):49-56
74. Martinez LS, Schwartz JS, Freres D, et al. Patient- clinician information engagement increases treatment decision satisfaction among cancer patients through feeling of being informed. Patient Educ Couns. 2009 Dec;77(3):384-390. Epub 2009 Oct 7
75. Rimer BK, Briss PA, Zeller PK, et al. Informed decision making: what is its role in cancer screening? Cancer. 2004 Sep 1;101(5 Suppl):1214-1228
76. BaruThM, Wilcox S, Laken M, Bopp M, Saunders R. Implementation of a faith- based physical activity intervention: insights from church healThdirectors. J Community Health. 2008 Oct;33(5):304-312
77. Friedman DB, Hooker SP, Wilcox S, et al. African American men's perspectives on promoting physical activity: "We're not that difficult to fi gure out!". J HealThCommun. 2012;17(10):1151-1170. Epub 2012 Jul 18
78. Colon- Otero G, Albertie M, Lesperance M, et al. A pilot program in collaboration wiThAfrican American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. J. Cancer Educ. 2012;27(2);294-298.